Open Government Canada
Reports of myocarditis and pericarditis after COVID-19 vaccination: Communiqué to health practitioners
Published by Public Health Agency of Canada | Agence de la santé publique du Canada
About this dataset
In May 2021, international reports of myocarditis (inflammation of the heart muscle) and pericarditis (inflammation of the lining around the heart) following vaccination with COVID-19 mRNA vaccines emerged, including from Israel and the United States. Follow-up on these cases is ongoing. No clear association has been established between myocarditis/pericarditis and mRNA vaccines, and to date, no regulatory action has been taken in Canada or internationally.
Tags
- Situation au Canada
- Reports of myocarditis
- pericarditis
- after COVID-19 vaccination
- Communiqué
- to health practitioners
- myocarditis
- COVID-19 vaccination
- vaccination
- COVID-19
- health practitioners
- mRNA
- COVID-19 vaccine
- safety efforts
- PHAC
- Public Health Agency of Canada
- Health Canada
- HC
- monitoring myocarditis
- in passive and active
- Canadian safety
- surveillance systems
- Canadian Adverse Events
- Immunization Surveillance System
- CAEFISS
- Canada Vigilance Program
- CV
- Canadian National
- Vaccine Safety Network
- CANVAS
- Canadian Immunization
- Monitoring Program ACTive
- (IMPACT)
- SRAS-CoV-2
- coronavirus
- COVID
- IMPACT
- inflammation of the heart muscle
- inflammation
- lining around the heart